1. India Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: other
Transchem Limited

Transchem Limited

BBSE:TRANSCHEM
418.75
INR
+1.75
(+0.42%)
5.74EPS
59.65P/E
4.19BMarket Cap
Transchem Limited
BSE:TRANSCHEM
(Bombay Stock Exchange)

Recent

price

418.75

P/E

ratio

59.65

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
INR
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.33
2.15
- -
- -
Revenue per Share
-2.29
-2.73
-1.08
-0.66
0.1
0.04
-0.18
-0.97
0.25
0.33
19.73
2.34
1.01
3.43
4.27
3.51
5.74
Basic EPS, GAAP
-4.48
1
1.49
0.47
0.86
0.83
0.45
-16.17
8.44
-0.52
-22.71
17.9
1
-32.12
29.41
-1.3
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
35.69
32.97
31.89
31.23
31.33
31.22
31.04
30.07
31.03
30.04
51.42
54.17
53.79
61.8
64.8
68.28
- -
Book Value per Share
35.69
32.97
31.89
31.23
31.33
31.22
31.04
30.07
31.03
30.04
51.42
54.17
53.79
61.8
64.8
68.28
- -
Tangible Book Value per Share
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
4
26
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-419.71
-55.87
- -
- -
Operating Margin (%)
15
15
15
15
11
10
10
10
8
6
1
- -
- -
- -
- -
- -
1
Depreciation Expense
-28
-33
-13
-8
1
- -
-2
-12
3
4
242
29
12
42
52
43
70
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
60.64
48.32
2.5
26.61
50.6
25.64
26.01
23.41
22.06
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1,025.22
198.67
- -
- -
Profit Margin (%)
303
281
269
261
273
281
290
295
279
296
544
576
578
668
773
815
- -
Working Capital
30
30
16
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
437
403
390
382
383
382
380
368
380
368
629
663
658
756
793
836
- -
Total Equity
- -
- -
- -
- -
0.31
- -
- -
- -
-2.21
-2.71
39.89
-3.13
-1.3
-1.8
-0.93
-1.96
- -
Return on Invested Capital (%)
- -
- -
- -
- -
0.31
- -
- -
- -
0.82
1.1
48.44
4.44
1.87
5.94
6.74
5.27
- -
Return on Capital (%)
-6.23
-7.94
-3.32
-2.08
0.31
0.12
-0.57
-3.18
0.82
1.1
48.44
4.44
1.87
5.94
6.74
5.27
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
12
12
12
Market Capitalization
2,241
1,991
4,187

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
855
- -
Cash, Cash Equivalents & STI
- -
427
- -
Accounts Receivable, Net
- -
22
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
40
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.72%
5.95%
5.37%
Free Cash Flow
-358.9%
-778.69%
-104.42%
Net Income, GAAP
568.27%
20.26%
-17.81%
Sales/Revenue/Turnover
- -
- -
-100%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
2
24
26
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1.36
1.18
1.13
0.6
4.27
2026
0.81
- -
0.43
1.71
3.51
2027
2.79
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -
Similar Companies
Cipla Ltd (NSE:CIPLA)
Aurobindo Pharma Ltd (NSE:AUROPHARMA)
Lupin Limited (NSE:LUPIN)
Granules India Limited (NSE:GRANULES)
Revolution Medicines, Inc. (NASDAQ:RVMD)
Egyptian International Pharmaceutical Industries Co. (EGX:PHAR)
Business
Transchem Limited (BSE: TRANSCHEM.BO), a public limited company listed on the Bombay Stock Exchange, engages in trading agricultural goods with no significant current operations. Incorporated in 1976 as a private limited company and converted to public limited status in 1992, the company is headquartered at 111 Maker Chambers IV, 11th Floor, Nariman Point, Mumbai, India, with a registered office at 304 Ganatra Estate, Pokhran Road No. 1, Khopat, Thane, Maharashtra. Historically, Transchem dealt in chemicals and pharmaceuticals before diversifying into mushroom production and processing in 1993, operating a mushroom plant in Talegaon village, Taluka Maval, District Pune; the plant currently stands non-operational due to shifts in the international horticulture market. In October 2025, the company enters into a non-binding term sheet to acquire Greshma Shares & Stocks Limited for cash consideration, aiming for 100% ownership pending due diligence, definitive agreements, board and regulatory approvals, with expected completion within three months; Greshma reported revenue of INR 113.2 million and equity of INR 158.9 million as of March 31, 2025. Transchem operates primarily in India, focusing on agricultural trading segments without active manufacturing or processing facilities at present.